Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or...
Reexamination Certificate
2004-08-02
2009-12-29
Swartz, Rodney P. (Department: 1645)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
C424S009100, C424S009200, C424S130100, C424S164100, C424S234100, C424S248100, C435S007100, C435S029000, C435S040500
Reexamination Certificate
active
07638271
ABSTRACT:
A method and kit for the detection of an infectious disease, particularly tuberculosis, wherein lymphocytes of a subject are incubated with a disease-specific antigen, and the level of antibody production is measured, the production of antibodies above a baseline level being indicative of infection.
REFERENCES:
patent: 5352580 (1994-10-01), Spears et al.
patent: 5478726 (1995-12-01), Shinnick et al.
patent: 5494799 (1996-02-01), Wood et al.
patent: 6120776 (2000-09-01), Hasløv et al.
patent: WO99/30162 (1999-06-01), None
Franco Ameglio, MD. et al., “Use of Discriminant Analysis to Assess Disease Activity in Pulmonary Tuberculosis with a Panel of Specific and Nonspecific Serum Markers,” American Journal Clinical Pathology, Rome, Italy, Jun. 1994, vol. 101, No. 6, pp. 719-725.
C. Saltini et al., “Soluble Immunological Markers of Disease Activity in Tuberculosis,” European Respiratory Journal, 1999, pp. 485-486.
Sudha Pottumarthy et al., “Evaluation of the Tuberculin Gamma Interferon Assay: Potential to Replace the Mantoux Skin Test,” Journal of Clinical Microbiology, vol. 37, No. 10, pp. 3229-3232.
M. S. Al-Hajjaj et al., “Improved Sensitivity for Detection of Tuberculosis Cases by a Modified Anda-TB ELISA Test,” Tubercle and Lung Disease, 1999, vol. 79, No. 3, pp. 181-185.
A. Yilmaz et al., “The Value of Ca 125 in the Evaluation of Tuberculosis Activity,” Respiratoy Medicine, 2001, vol. 95, pp. 666-669.
Robin E. Huebner et al., “Tuberculosis Commentary,” Clinical Infectious Diseases, 1993, vol. 17, pp. 968-975.
Paul E. M. Fine et al., “Delayed-Type hypersensitivity, Mycobacterial Vaccines and Protective Immunity,” The Lancet, Nov. 5, 1994, vol. 344, pp. 1245-1249.
R. Dhand et al., “False-Positive Reactions with Enzyme-Linked Immunosorbent Assay of Mycobacterium Tuberculosis Antigens in Pleural Fluid,” Journal of Medical Microbiology, vol. 26, issue 4, p. 241 (abstract).
Wang CR et al., “Enzyme-linked Immunosorbent Assay with BCG Sonicate Antigen for Diagnostic Potential of Mycobacterial Infection in Taiwan,” National Library of Medicine, Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi, May 1989, vol. 22, No. 2, p. 97 (abstract).
A. Aoki et al. “Their Tilters and Recognized Molecules of IgG Class Anti-BCG Antibody in Sera from Patients with Tuberculosis,” National Library of Medicine, Nihon Kyobu Shikkan Gakkai Zasshi, May 1990, pp. 729-735 (abstract).
N. Banchuin et al., “Value of an ELISA for Mycobacterial Antigen Detection as a Routine Diagnostic Test of Pulmonary Tuberculosis,” National Library of Medicine, Asian Pac J Allergy Immunol., Jun. 1990, p. 5 (abstract).
Chuan-Zhen Lu et al., “Early Diagnosis of Tuberculous Meningitis by Detection of Anti-BCG Secreting Cells in Cerebrospinal Fluid,” The Lancet, Jul. 1990, vol. 336, pp. 10-14.
Sandra M. Arend et al. “Detection of Active Tuberculosis Infection by T Cell Responses to Early-Secreted Antigenic Target 6-kDa Protein and Culture Filtrate Protein 10,” The Journal of Infectious Diseases, 2000, vol. 181, pp. 1850-1854.
John M. Pollock et al., “The Potential of the ESAT-6 Antigen Secreted by Virulent Mycobacteria for Specific Diagnosis of Tuberculosis,” Journal of Infectious Diseases, 1997, vol. 175, pp. 1251-1254.
Laurens A. H. van Pinxteren et al., “Diagnosis of Tuberculosis Based on the Two Specific Antigens ESAT-6 and CFP10,” Clinical and Diagnostic Laboratory Immunology, Mar. 2000, vol. 7, pp. 155-160.
J.M. Querol et al., “Usefulness of IgG and IgM Detection Against Antigen 60 in the Diagnosis of Thoracic Tuberculosis,” National Library of Medicine, An Med. Intern., Jun. 1993, vol. 10, p. 271 (abstract).
S.M. Qadri et al., “Nonspecificity of the Anda A60-tb ELISA Test for Serodiagnosis of Mycobacterial Disease,” National Library of Medicine, Can J Microbiol, Aug. 1992, vol. 8, p. 804 (abstract).
R.F. Maes, “Evaluation of the Avidity of IgG Anti-Mycobacterial Antibodies in Tuberculous Patients Serum by an A-60 Immunoassay.” National Library of Medicine, Euro J. Epidemiol, Mar. 1991, vol. 7, pp. 188-190 (abstract).
C. Delacourt et al., “Value of ELISA Using Antigen 60 for the Diagnosis of Tuberculosis in Children,” Chest, 1993, vol. 104, p. 393 (abstract).
M. Turneer et at., “Determination of Humoral Immunoglobulins M and G Directed Against Mycobacterial Antigen 60 Failed to Diagnose Primary Tuberculosis and Mycobacterial Adenitis in Children,” American Journal of Respiratory and Critical Care Medicine, Dec. 1994, vol. 150, No. 6, p. 1508 (abstract).
Johan Vekemans et al., “Tuberculosis Contacts but Not Patients have Higher Gamma Interferon Responses to ESAT-6 than Do Community Controls in The Gambia,” Infection and Immunity, Oct. 2001 ,vol. 69, pp. 6554-6557.
Konstantin Ly Ashchenko et al., “Heterogeneous Antibody Responses in Tuberculosis,” Infection and Immunity, Aug. 1998, vol. 66, pp. 3936-3940.
H. Sunny Chang et al., “Development of a Novel in Vitro Assay (ALS Assay) for Evaluation of Vaccine-Induced Antibody Secretion from Circulating Mucosal Lymphocytes,” Clinical and Diagnostic Laboratory Immunology, May 2001, vol. 8, No. 3, pp. 482-488.
A. O. Sousa et al., “Kinetics of Circulating Antibodies, Immune Complex and Specific Antibody-Secreting Cells in Tuberculosis Patients During 6 Months of Antimicrobial Therapy,” Tubercle and Lung Disease, 2000, vol. 80, No. 1, pp. 27-33.
Rubhana Raqib et al., “Rapid Diagnosis of Active Tuberculosis by Detecting Antibodies from Lymphocyte Secretions,” J. Infect. Dis., Aug. 2003, vol. 188, pp. 364-370.
Rubhana Raqib et at., “Use of Antibodies in Lymphocyte Secretions for Detection of Subclinical Tuberculosis Infection in Asymptomatic Contacts,” Clinical and Diagnostic Laboratory Immunology, Nov. 2004, vol 11, No. 6, pp. 1022-1027.
Raquib Rubhana
Sack David A.
Hobbs Ann S.
ICDDR, B: The Center for Health and Population Research
Swartz Rodney P.
Venable LLP
LandOfFree
Use of antibody from lymphocyte secretions to diagnose... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of antibody from lymphocyte secretions to diagnose..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of antibody from lymphocyte secretions to diagnose... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4142103